Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Report
  • Published:

Sildenafil use in patients with olanzapine-induced erectile dysfunction

Abstract

In the present study, we aimed to examine the efficacy of sildenafil in patients with an antipsychotic (olanzapine)-induced erectile dysfunction (ED). The study group comprised 10 patients who experienced ED associated with the use of olanzapine. The patients initially received 50 mg sildenafil at baseline. If clinically indicated, titration up to 100 mg was permitted. All patients were assessed by Clinical Global Impression-Improvement (CGI-I) and International Index of Erectile Dysfunction (IIEF) scales at baseline and weeks 2 and 4. At final assessment, three patients were considered ‘very much improved’ and four ‘much improved’ according to CGI-I. Our results suggest that sildenafil use is effective and well-tolerated in patients with olanzapine-induced ED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Peuskens J, Sienaert P, DeHert M . Sexual dysfunction: the unspoken side effect of antipsychotics Eur Psychiat 1998; 13: 235–305.

    Article  Google Scholar 

  2. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C . Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 1996; 8: 47–52.

    CAS  PubMed  Google Scholar 

  3. Atmaca M, Kuloglu M, Tezcan E, Gecici O . Antidepresan kullanimina baǧli erektil disfonksiyonda sildenafil kullanimi Klinik Psikofarmakoloji Bülteni 2001; 11: 106–110 (in Turkish).

    Google Scholar 

  4. Segraves RT . Two additional uses for sildenafil in psychiatric patients J Sex Marital Ther 1999; 25: 265–266.

    Article  CAS  PubMed  Google Scholar 

  5. Benatov R, Reznik I, Zemishlany Z . Sildenafil citrate (viagra) treatment of sexual dysfuction in a schizophrenic patient Eur Psychiat 1999; 14: 353–355.

    Article  CAS  Google Scholar 

  6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington, DC: American Psychiatric Association Press 1994.

  7. Guy W . ECDEU Assessment Manual for Psychopharmacology National Institute of Mental Health: Rockville 1976 218–222.

  8. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 1997; 49: 882–890.

    Article  Google Scholar 

  9. Balon R . Fluvoxamine-induced erectile dysfunction responding to sildenafil J Sex Marital Ther 1998; 24: 313–317.

    Article  CAS  PubMed  Google Scholar 

  10. Fava M, Rankin MA, Alpert JE, Nierenherg AA, Worthington JJ . An open trial of oral sildenafilin antidepressant induced sexual dysfunction Psychother Psychosom 1998; 67: 328–331.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Atmaca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atmaca, M., Kuloglu, M. & Tezcan, E. Sildenafil use in patients with olanzapine-induced erectile dysfunction. Int J Impot Res 14, 547–549 (2002). https://doi.org/10.1038/sj.ijir.3900906

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900906

Keywords

This article is cited by

Search

Quick links